Centre for Policy on Ageing
 

 

New drugs for Alzheimer's disease
Author(s)Alistair Burns, Eve Russell, Sean Page
Journal titleBritish Journal of Psychiatry, vol 174, June 1999
Pagespp 476-479
KeywordsDementia ; Drugs.
AnnotationA new class of agents, cholinesterase inhibitors, is now available for the symptomatic treatment of Alzheimer's disease (AD). The drugs concerned are: tetrahydroaminoacridine (tacrine), donepezil hydrochloride, and rivastigmine. This article briefly reviews these new drugs, and outlines the implications for psychiatrists. Studies of other drugs - metrifonate, and other anticholinesterase agents - are also summarised. (RH).
Accession NumberCPA-990716225 A
ClassmarkEA: LLD

Data © Centre for Policy on Ageing

...from the Ageinfo database published by Centre for Policy on Ageing.
 

CPA home >> Ageinfo Database >> Queries to: webmaster@cpa.org.uk